About PeopleBio R&D
PeopleBio R&D is a company based in Seongnam-si (South Korea) founded in 2002. The company has 60 employees as of December 31, 2024. PeopleBio R&D operates in a competitive market with competitors including Cytox, ADx NeuroSciences, Amprion, Durin Technologies and Adlyfe, among others.
- Headquarter Seongnam-si, South Korea
- Employees 60 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Peoplebio. Inc.
-
Annual Revenue
$2.53 M (USD)-16.2as on Dec 31, 2024
-
Net Profit
-$7.4 M (USD)31.94as on Dec 31, 2024
-
EBITDA
-$6.77 M (USD)27.03as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
60
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PeopleBio R&D
PeopleBio R&D is a publicly listed company on the KRX with ticker symbol 304840 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of PeopleBio R&D
Detailed funding history for PeopleBio RD
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PeopleBio R&D
Investment portfolio details for PeopleBio RD
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PeopleBio RD
Detailed financials for PeopleBio RD
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Peoplebio R&D Comparisons
Peer comparison for PeopleBio RD
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PeopleBio R&D
PeopleBio R&D operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytox, ADx NeuroSciences, Amprion, Durin Technologies and Adlyfe, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Prognostic tests for assessing dementia risk are developed.
|
|
| Locked | Locked | Locked |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| Locked | Locked | Locked |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| Locked | Locked | Locked |
Developer of the diagnostic test for neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Develops biomarkers and diagnostic tests for amyloid-related diseases.
|
Detailed competitors of PeopleBio RD
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Peoplebio R&D
Complete news archive for PeopleBio RD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PeopleBio R&D
PeopleBio R&D was founded in 2002.
PeopleBio R&D is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
As of Dec 31, 2024, the latest employee count at PeopleBio R&D is 60.
Annual revenue of PeopleBio R&D is $2.53M as on Dec 31, 2024.
PeopleBio RD was founded in 2002 in Seongnam-si, South Korea, as a molecular diagnostics firm. Focus is placed on immunoassays for detecting neurodegenerative conditions like Alzheimers and Parkinsons. The Multimer Detection System platform is utilized, involving sandwich ELISA tests with capturing and detection antibodies to identify protein multimers in CSF, plasma, exosomes, and body fluids. Tests are also created for therapeutic antibodies and spongiform encephalopathies.
PeopleBio R&D's top competitors include Amprion, ADx NeuroSciences and Cytox.
Yes, PeopleBio R&D is publicly traded on KRX under the ticker symbol 304840.
The ticker symbol of PeopleBio R&D is 304840 on KRX.